Wide-bore MR covers wide-bodied patients
Physical examination of bariatric patients is challenging. Radiology can play an important role, but only if the patients can be imaged. They sometimes cannot fit comfortably into a cylindrical high-field MR system. As a result, physicians may refer patients to lower field open systems, but lower field strength can pose a problem. The Magnetom Espree offers a solution.
Physical examination of bariatric patients is challenging. Radiology can play an important role, but only if the patients can be imaged. They sometimes cannot fit comfortably into a cylindrical high-field MR system. As a result, physicians may refer patients to lower field open systems, but lower field strength can pose a problem. The Magnetom Espree offers a solution.
Siemens' 1.5T scanner, which produced the whole-body image shown, offers more room than a traditional MR unit, addressing issues related to both obesity and claustrophobia. With its 70-cm-diameter bore, the Espree looks more like a CT than an MR scanner. The average distance between a patient's head and the magnet is 30 cm.
Equipped with TIM (total imaging matrix) technology, Espree delivers high-resolution images in a range of applications. The matrix body coil comprises up to 76 elements that can be combined with up to 32 RF channels, producing a signal-to-noise ratio four or more times higher than that of traditional open MR designs.
The Espree is just one of the Siemens' technologies that are being used to image bariatric patients; the company also offers the Somatom Sensation Open, a CT scanner with a gantry aperture and field-of-view measuring 82 cm in diameter. It is specifically designed for use in oncology, emergency medicine, interventional CT, and bariatrics. (Provided by Siemens Medical Solutions)
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
